top of page
Wavy Texture

Molecular (RT-PCR) Testing


Molecular Testing for Respiratory Pathogens

According to the World Health Organization (WHO), RTIs are the leading cause of disease burden worldwide caused by microbes such as viruses, bacteria, and even fungi. Conventional diagnostic approaches such as culture and antigen-based detection provide limited answers and are prone to contamination.

Our real-time PCR-based respiratory pathogen panel (RPP) is a sensitive, syndromic, flexible-content solution for detecting respiratory pathogens in less than 12 hours.

Our Open Array solution will catch up to 35 different bacterial and viral pathogens, including COVID-19. 



Urinary Tract Infection (UTI) Panel + Sexually Transmitted Infection (STI) Combo Panel

UTIs are considered among the most prevalent diseases globally, affecting approximately 250 million people and resulting in 150 million deaths each year.

According to the WHO, more than 1 million STIs are acquired every day. In 2020, chlamydia, gonorrhea, syphilis, and trichomoniasis accounted for an estimated 374 million STIs.

Routine diagnostic methods such as culture, antigen detection, serology, and biochemical lack sensitivity, specificity, and take a long time (current culture plating take 18 - 30 hours)


Our real-time-PCR technology enables quick turnaround time of UTI/STI detection in under 5 hours allowing for flexible content and optimized for multiple outputs. 

Our PCR UTI/STI test detects up to 32 pathogens. From a single urine sample, we can test not only for UTIs but also STDs. 


According to the National Institutes of Health (NIH), about 6.7 million people in the U.S. are affected by chronic wounds. Infected wounds can lead to longer-term care, pain, stress, depression, and other health complications.


Our RT PCR-based Swab Test offers:


  • 99% Accurate PCR

  • Results in under 5 hours of Lab receipt

  • Detection of 18 different pathogens

  • Patient-Specific Antibiotic Resistance


When it comes to gastrointestinal problems viruses are often the most prevalent and least tested for. Traditional testing for bacteria, while commonly done, is often positive in only 5% or fewer of cases.


Molecular genetic testing offers exceptional sensitivity and excellent specificity for bacteria, viruses, and even parasites.


Symptoms to Consider

  • Abdominal pain or left quadrant pain

  • Abnormal loss of weight

  • Blood in stool

  • Colitis, enteritis, and gastroenteritis

  • Functional diarrhea or diarrhea of infectious origin

  • Nausea with vomiting

  • Fever

  • Viral enteritis and non-infectious gastroenteritis


Bacterial Vaginosis (BV) affects millions of women and is associated with several serious health conditions. Bacterial vaginosis is a type of vaginal inflammation caused by the overgrowth of bacteria naturally found in the vagina, which upsets the natural balance.


This condition is increasingly recognized as causing common and costly obstetric and gynecologic infectious complications worldwide. The prevalence of BV is difficult to determine as the disease can be symptomatic or asymptomatic. The bacteria associated with BV are considered Fastidious Vaginal Microorganisms (FVMs), that are either difficult to culture or, in some cases, have yet to be cultured. As a consequence, the use of molecular techniques to detect FVMs are critical for the clinician to make an accurate BV diagnosis. 


To improve the diagnosis of BV, PCL utilizes a Bacterial Vaginosis panel of Real-time PCR assays to detect a combination of BV-associated organisms.


Onychomycosis is the common disease of the toenail. It is the cause of roughly 50% of nail deformities and effects approximately 14-18% of adults. It is important to identify the pathology of the nail deformation and determine a proper treatment plan.  Traditional diagnosis for onychomycosis includes a microscopy and culture testing and can take up to two weeks. 


With PGL + PCL there’s no need to wait. You’ll get fast and 99% accurate results for bacteria and fungus within 24 hours of sample receipt.


The AntiBiogram report offers semi-quantitative data for any detected targets in a UTI, wound or UTI/WP test panel. Antibiotic sensitivity and resistance data is provided for the detected bacteria to help guide providers in treating their patients most effectively.


Questions about our services? 

bottom of page